Glaxo Holdings
Executive Summary
Appointment of a non-executive chairman to succeed chairman and director Paul Girolami "will be made in due course," company says June 15. Girolami will retire, effective Nov. 18, a year earlier than previously planned. "To ensure an orderly transition," Girolami will complete the transfer of executive duties on June 30, the end of Glaxo's fiscal year, the company notes. With his retirement, Glaxo CEO and Deputy Chairman Richard Sykes holds the firm's most senior executive position